GenVec - GNVC | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
GenVec - GNVC

An SI Board Since March 2010

Posts	SubjectMarks	Bans	Symbol
106	9	0	GNVC

Emcee: caly	Type: Moderated

Introduction Market Data Compact

GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company developing novel gene-based therapeutic drugs and vaccines.

Website: genvec.com

Press Releases: genvec.com

Google Finance News: google.com

SEC Filings: sec.gov

Shares Outstanding -

As of 10/31/2009, 106,335,723 shares
As of 10/31/2008, 88,422,96 shares

Stock Quote: google.com

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
106	If anyone has the certainty that the hearing drug will be approved, or one of th	Gary Mohilner	-	2/6/2017
105	Dogs run in packs... likely more to come sniffin' around.... NEW ORLEANS, Fe	Savant	-	2/3/2017
104	Agreed, the law dogs are likely trolling for 'ungruntled' shareholders..	Savant	-	2/2/2017
103	I've never been a big fan of attorney's who take actions to get involved	Gary Mohilner	-	2/2/2017
102	Brower Piven Commences An Investigation Into The Proposed Sale Of GenVec, Inc. A	Savant	-	2/2/2017
101	Exemplar Genetics Awarded Subcontract to Advance New Therapeutic Models for Sick	Savant	-	1/30/2017
100	I really can't say what drove the price up before, but it's very possibl	Gary Mohilner	-	1/24/2017
99	Seems someone knew when it popped to 10+... Intrexon to Acquire GenVec to Expan	Savant	-	1/24/2017
98	Here's a link to the Presentation that's being made tomorrow: content.e	Gary Mohilner	1	1/17/2017
97	GenVec, Inc. (NASDAQ: GNVC), a clinical-stage gene delivery company, announced t	Savant	-	1/11/2017
96	With less than 2.5 million shares outstanding, they've traded over 17 millio	Gary Mohilner	-	1/10/2017
95	Seems to be alive...lol...moved up to $10.44 today on high vol, retracing now	Savant	-	1/10/2017
94	This is certainly a sign that GNVC is alive with ideas, the question is, how wil	Gary Mohilner	-	1/5/2017
93	GNVC jumped today on news to $4.47...retraced some GenVec Signs Option Agreemen	Savant	-	1/5/2017
92	Hopefully GNVC is now positioned to move dramatically on any positive news. I b	Gary Mohilner	-	12/1/2016
91	GenVec, Inc. (NASDAQ: GNVC) ("GenVec" or "the Company") anno	Savant	-	12/1/2016
90	Thanks, I was aware this was happening, but unsure of the day and time of the pr	Gary Mohilner	-	9/28/2016
89	GAITHERSBURG, Md., Sept. 28, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC), a	Savant	-	9/28/2016
88	I believe we should get official word of a 6 months extension of the Nasdaq dead	Gary Mohilner	-	8/21/2016
87	Get well soon. And yes, pneumonia is a v.serious condition. One doesn't imm	Savant	-	8/11/2016
86	Savant, I had written the company in the hopes that they'd both hold a webc	Gary Mohilner	-	8/11/2016
85	GAITHERSBURG, Md., Aug. 5, 2016 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) toda	Savant	-	8/5/2016
84	Y, takes fda a long time to boil water...hence, the reason I've named them..	Savant	-	7/26/2016
83	All those interested in the company knew the trial would resume, I'm uncerta	Gary Mohilner	-	7/26/2016
82	GM, a bit of positive news...Clinical resumed, after FDA review.. FDA Lifts Cli	Savant	-	7/26/2016

Go to reply# or date (mm/dd/yy):